应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ABP ABPRO HLDGS INC
交易中 02-12 14:03:30 EST
0.9315
-0.3385
-26.65%
最高
1.20
最低
0.8951
成交量
129.62万
今开
1.13
昨收
1.27
日振幅
24.01%
总市值
253.02万
流通市值
93.73万
总股本
271.63万
成交额
129.50万
换手率
128.81%
流通股本
100.62万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Abpro Holdings, Inc盘中异动 早盘股价大涨75.66%
市场透视 · 02-10 22:31
Abpro Holdings, Inc盘中异动 早盘股价大涨75.66%
Abpro Holdings, Inc盘中异动 早盘股价大涨6.48%报2.50美元
市场透视 · 01-29
Abpro Holdings, Inc盘中异动 早盘股价大涨6.48%报2.50美元
Abpro与Celltrion达成全球合作 临床试验预计2026年上半年启动
美股速递 · 01-06
Abpro与Celltrion达成全球合作 临床试验预计2026年上半年启动
Abpro与Celltrion宣布其领先多特异性抗体抗癌候选药物Abp-102/Ct-P72获美国FDA IND许可
美股速递 · 01-06
Abpro与Celltrion宣布其领先多特异性抗体抗癌候选药物Abp-102/Ct-P72获美国FDA IND许可
Abpro Holdings, Inc盘中异动 早盘股价大跌5.69%
市场透视 · 01-06
Abpro Holdings, Inc盘中异动 早盘股价大跌5.69%
ABPRO HLDGS INC提交IND申请以启动Abp-102/Ct-P72针对HER2阳性癌症的I期临床试验
美股速递 · 2025-12-15
ABPRO HLDGS INC提交IND申请以启动Abp-102/Ct-P72针对HER2阳性癌症的I期临床试验
ABPRO控股公司提交有关可发行和转售高达978万股普通股的招股说明书 - SEC文件
投资观察 · 2025-11-20
ABPRO控股公司提交有关可发行和转售高达978万股普通股的招股说明书 - SEC文件
ABPRO HLDGS INC:提交关于提供和转售高达978万股普通股的招股说明书 - SEC备案
美股速递 · 2025-11-07
ABPRO HLDGS INC:提交关于提供和转售高达978万股普通股的招股说明书 - SEC备案
Meta(META)跌超2% 遭荷兰养老金基金ABP清仓
金吾财讯 · 2025-02-18
Meta(META)跌超2% 遭荷兰养老金基金ABP清仓
美股异动|Meta跌超1.6% 遭荷兰养老基金ABP清仓
港股那点事 · 2025-02-18
美股异动|Meta跌超1.6% 遭荷兰养老基金ABP清仓
Meta(META.US)、Alphabet(GOOGL.US)步特斯拉(TSLA.US)后尘!遭荷兰养老基金ABP清仓
智通财经 · 2025-02-17
Meta(META.US)、Alphabet(GOOGL.US)步特斯拉(TSLA.US)后尘!遭荷兰养老基金ABP清仓
美股异动 | 遭欧洲最大的养老基金ABP清仓 特斯拉(TSLA.US)盘前跌3%
智通财经 · 2025-01-13
美股异动 | 遭欧洲最大的养老基金ABP清仓 特斯拉(TSLA.US)盘前跌3%
不满意马斯克薪酬方案,欧洲最大养老基金ABP清仓特斯拉
微博财经-财道工作室 · 2025-01-13
不满意马斯克薪酬方案,欧洲最大养老基金ABP清仓特斯拉
加载更多
公司概况
公司名称:
ABPRO HLDGS INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Abpro Holdings, Inc.于2021年5月20日在特拉华州注册成立。该公司是一家生物技术公司,致力于开发下一代抗体疗法,旨在改善严重和危及生命的疾病患者的生活。Abpro专注于免疫肿瘤学和眼科的新型抗体构建。通过利用其专有的DiversImmune和MultiMabTM抗体发现和工程平台,Abpro正在独立或通过与全球制药和研究机构的合作开发下一代抗体管道。
发行价格:
--
{"stockData":{"symbol":"ABP","market":"US","secType":"STK","nameCN":"ABPRO HLDGS INC","latestPrice":0.9315,"timestamp":1770922841917,"preClose":1.27,"halted":0,"volume":1296165,"delay":0,"changeRate":-0.26653543307086613,"floatShares":1006226,"shares":2716278,"eps":-11.895451,"marketStatus":"交易中","change":-0.3385,"latestTime":"02-12 14:03:30 EST","open":1.13,"high":1.2,"low":0.8951,"amount":1295027.3559795,"amplitude":0.240079,"askPrice":0.9649,"askSize":100,"bidPrice":0.9,"bidSize":258,"shortable":0,"etf":0,"ttmEps":-11.895451,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770930000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1526011200000,"exchange":"NASDAQ","adjPreClose":1.27,"preHourTrading":{"tag":"盘前","latestPrice":1.13,"preClose":1.27,"latestTime":"09:29 EST","volume":239723,"amount":253449.37117389997,"timestamp":1770906557442,"change":-0.14,"changeRate":-0.110236,"amplitude":0.181339},"postHourTrading":{"tag":"盘后","latestPrice":1.25,"preClose":1.27,"latestTime":"19:59 EST","volume":97938,"amount":118484.1199,"timestamp":1770857991421,"change":-0.02,"changeRate":-0.015748,"amplitude":0.11},"volumeRatio":0.10069},"requestUrl":"/m/hq/s/ABP","defaultTab":"news","newsList":[{"id":"2610372279","title":"Abpro Holdings, Inc盘中异动 早盘股价大涨75.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610372279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610372279?lang=zh_cn&edition=full","pubTime":"2026-02-10 22:31","pubTimestamp":1770733885,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日22时31分,Abpro Holdings, Inc股票出现波动,股价急速上涨75.66%。Abpro Holdings, Inc股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Quince Therapeutics, Inc.、Abpro Holdings, Inc、Evommune, Inc.涨幅较大,Abpro Holdings, Inc、Phio Pharmaceuticals Corp.、Quince Therapeutics, Inc.较为活跃,换手率分别为966.30%、615.27%、407.39%,振幅较大的相关个股有Quince Therapeutics, Inc.、Abpro Holdings, Inc、Liminatus Pharma, Inc.,振幅分别为16.62%、15.79%、9.58%。Abpro Holdings, Inc公司简介:Abpro Holdings Inc 是一家致力于开发下一代抗体疗法的生物技术公司,其目标是改善患有严重和危及生命疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223125a49405ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223125a49405ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"2607067989","title":"Abpro Holdings, Inc盘中异动 早盘股价大涨6.48%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607067989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607067989?lang=zh_cn&edition=full","pubTime":"2026-01-29 22:39","pubTimestamp":1769697540,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日22时39分,Abpro Holdings, Inc股票出现波动,股价大幅上涨6.48%。截至发稿,该股报2.50美元/股,成交量1.4446万股,换手率0.53%,振幅4.25%。Abpro Holdings, Inc股票所在的生物技术行业中,整体涨幅为0.14%。Abpro Holdings, Inc公司简介:Abpro Holdings Inc 是一家致力于开发下一代抗体疗法的生物技术公司,其目标是改善患有严重和危及生命疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012922390097a4033e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012922390097a4033e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"1193338956","title":"Abpro与Celltrion达成全球合作 临床试验预计2026年上半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1193338956","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193338956?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:01","pubTimestamp":1767700881,"startTime":"0","endTime":"0","summary":"ABPRO HLDGS INC近日宣布,通过与韩国生物制药企业Celltrion的全球战略合作,其创新药物临床试验计划预计将于2026年上半年正式启动。此次合作将整合Abpro在抗体疗法领域的技术优势与Celltrion的规模化生产实力,共同推进肿瘤治疗领域的研发进程。根据双方协议,Abpro将负责前期研发及临床方案设计,Celltrion则承担临床阶段的生产供应与全球商业化支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"1133031799","title":"Abpro与Celltrion宣布其领先多特异性抗体抗癌候选药物Abp-102/Ct-P72获美国FDA IND许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1133031799","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133031799?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:01","pubTimestamp":1767700876,"startTime":"0","endTime":"0","summary":"Abpro公司与Celltrion公司联合宣布,其核心多特异性抗体抗癌候选药物Abp-102(亦称为Ct-P72)已获得美国食品药品监督管理局(FDA)的新药临床试验(IND)批准。\n这一重要进展标志着该创新疗法正式获准进入临床开发阶段,为后续的人体试验铺平道路。Abp-102/Ct-P72作为一种多特异性抗体,旨在通过靶向多个癌症信号通路,更有效地攻击肿瘤细胞。\n此次IND获批是基于临床前研究显示的积极数据,证明了其在治疗特定癌症类型方面的潜力。两家公司计划迅速推进临床试验,以评估该药物在患者中的安全性和有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"2601483161","title":"Abpro Holdings, Inc盘中异动 早盘股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601483161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601483161?lang=zh_cn&edition=full","pubTime":"2026-01-06 00:17","pubTimestamp":1767629820,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日00时17分,Abpro Holdings, Inc股票出现波动,股价急速下挫5.69%。Abpro Holdings, Inc股票所在的生物技术行业中,整体跌幅为1.80%。Abpro Holdings, Inc公司简介:Abpro Holdings Inc 是一家致力于开发下一代抗体疗法的生物技术公司,其目标是改善患有严重和危及生命疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106001700953c05cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106001700953c05cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"1137956025","title":"ABPRO HLDGS INC提交IND申请以启动Abp-102/Ct-P72针对HER2阳性癌症的I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1137956025","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137956025?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:02","pubTimestamp":1765800144,"startTime":"0","endTime":"0","summary":"ABPRO HLDGS INC提交IND申请以启动Abp-102/Ct-P72针对HER2阳性癌症的I期临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABP"],"gpt_icon":0},{"id":"1141509871","title":"ABPRO控股公司提交有关可发行和转售高达978万股普通股的招股说明书 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1141509871","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141509871?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:08","pubTimestamp":1763572117,"startTime":"0","endTime":"0","summary":"11月7日 - ABPRO控股公司宣布,已向美国证券交易委员会(SEC)提交招股说明书,内容涉及可发行和转售高达978万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"1105117866","title":"ABPRO HLDGS INC:提交关于提供和转售高达978万股普通股的招股说明书 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1105117866","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105117866?lang=zh_cn&edition=full","pubTime":"2025-11-07 20:45","pubTimestamp":1762519515,"startTime":"0","endTime":"0","summary":"ABPRO HLDGS INC:提交关于提供和转售高达978万股普通股的招股说明书 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABP","BK4139"],"gpt_icon":0},{"id":"2512716156","title":"Meta(META)跌超2% 遭荷兰养老金基金ABP清仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2512716156","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512716156?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:22","pubTimestamp":1739892174,"startTime":"0","endTime":"0","summary":"金吾财讯 | Meta(META)股价走低,截至发稿,跌2.38%,报719.17美元,成交额40.67亿美元。欧洲最大养老基金之一Stichting Pensioenfonds ABP(简称“ABP”)的首席执行官Harmen van Wijnen周一在接受采访时表示,该基金已出售持有的Meta和Alphabet(GOOGL)的所有股票,称这些公司不再符合该基金的治理标准。ABP是荷兰政府与教育机构雇员的养老金基金,管理着5440亿欧元的资产。ABP曾在去年表示,将削减对气候影响较大的投资,同时将更多资金投向有助于改善社会和环境的公司的项目。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/Y2U1MTljZjZkNTgxMTYyODU5MDU0MTEzOA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2U1MTljZjZkNTgxMTYyODU5MDU0MTEzOA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"285541","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","GOOGL","IE00B19Z3581.USD","LU0528227936.USD","ABP","BK4503","LU2213496289.HKD","LU2430703095.HKD","IE00BKVL7J92.USD","SG9999018857.SGD","BK4533","LU1267930490.SGD","LU1244550577.SGD","LU2360032135.SGD","LU1003077747.HKD","LU0310800965.SGD","LU0417517546.SGD","LU0957808578.USD","IE00BQXX3D17.EUR","LU0170899867.USD","IE00B19Z8W00.USD","BK4598","LU1697837992.HKD","LU2491049909.HKD","BK4550","LU0742534661.SGD","LU1823568750.SGD","LU1564329628.SGD","LU0820562030.AUD","LU1280957306.USD","LU2756315664.SGD","LU1221951129.SGD","LU0323591593.USD","LU0203345920.USD","LU2326559502.SGD","META","LU1066051811.HKD","LU1506573853.SGD","LU2087621335.USD","LU0048584097.USD","LU0130103400.USD","LU1119994496.HKD","LU1670710588.SGD","LU1732799900.SGD","LU0251131958.USD","LU1951200564.SGD","IE0034235188.USD","LU1032955483.USD","LU1244550494.USD","LU1868836914.USD"],"gpt_icon":0},{"id":"2512166384","title":"美股异动|Meta跌超1.6% 遭荷兰养老基金ABP清仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166384","media":"港股那点事","labels":["shareholding","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166384?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:48","pubTimestamp":1739890080,"startTime":"0","endTime":"0","summary":"格隆汇2月18日|Meta Platforms(META.US)跌超1.6%,报724.83美元。消息面上,欧洲最大养老基金之一Stichting Pensioenfonds(ABP)的首席执行官Harmen van Wijnen周一在接受采访时表示,该基金已出售持有的Meta Platform和谷歌的所有股票,称这些公司不再符合该基金的治理标准。ABP是荷兰政府与教育机构雇员的养老金基金,管理着5440亿欧元的资产。(格隆汇)\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-02-18/doc-inekxmra6491457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","ABP"],"gpt_icon":0},{"id":"2512285944","title":"Meta(META.US)、Alphabet(GOOGL.US)步特斯拉(TSLA.US)后尘!遭荷兰养老基金ABP清仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2512285944","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512285944?lang=zh_cn&edition=full","pubTime":"2025-02-17 20:26","pubTimestamp":1739795189,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,欧洲最大养老基金之一Stichting Pensioenfonds ABP的首席执行官Harmen van Wijnen周一在接受采访时表示,该基金已出售持有的Meta和Alphabet的所有股票,称这些公司不再符合该基金的治理标准。与特斯拉的股票一样,ABP也是在去年第三季度抛售了所持的Meta和Alphabet的股票。而据报道,截至2024年第二季度,ABP持有的Alphabet、Meta股票价值分别为30亿欧元和20亿欧元。而Meta首席执行官扎克伯格和Alphabet首席执行官皮查伊则分别向特朗普的就职委员会捐赠了100万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0c6c7cf4c5f6666db587886e2c9c1898","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0061475181.USD","LU0690374961.EUR","LU0648000940.SGD","TSYW.SI","LU2237443622.USD","LU1934455194.USD","GOOGL","LU0029864427.USD","IE00BKVL7J92.USD","LU2063271972.USD","IE00BQXX3F31.USD","LU0426417589.USD","IE00BMPRXQ63.HKD","LU2237443978.SGD","TSLL","IE0034235303.USD","LU1506573853.SGD","LU0211328371.USD","LU0316494557.USD","LU0477156797.USD","LU2237443895.HKD","LU2264538146.SGD","LU1037948541.HKD","USJW.SI","LU1066051225.USD","LU0348723411.USD","LU1791710582.SGD","LU2505996509.AUD","BK4579","IE0005OL40V9.USD","ABP","LU0289960550.SGD","IE0009356076.USD","LU0203347892.USD","LU0342679015.USD","LU1691799644.USD","LU2750360641.GBP","LU0154236417.USD","LU1235294995.USD","META","TSLA","LU0456855351.SGD","BK4532","BK4551","LU1699723380.USD","GOOG","LU0345768153.USD","LU0345774631.USD","LU2430703251.USD","LU0912757837.SGD"],"gpt_icon":1},{"id":"2503300670","title":"美股异动 | 遭欧洲最大的养老基金ABP清仓 特斯拉(TSLA.US)盘前跌3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503300670","media":"智通财经","labels":["shareholding","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503300670?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:12","pubTimestamp":1736777556,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周一,特斯拉(TSLA.US)美股盘前跌3%,报382.81美元。消息面上,日前,欧洲最大的养老基金ABP透露,已在去年第三季度出售了其所持有的特斯拉全部5.71亿欧元股份,部分原因是对马斯克的薪酬方案存在分歧。去年6月份,ABP曾投票反对马斯克价值500多亿美元的薪酬方案,称其“存在争议,而且薪酬过高”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"15049e06a9470364b90024adeef183b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1237077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","LU1720051017.SGD","LU1914381329.SGD","BK4533","LU1861215975.USD","TSYW.SI","LU0345769128.USD","SG9999015986.USD","LU2213496289.HKD","BK4585","LU0689472784.USD","LU2602419157.SGD","LU0348723411.USD","LU0719512351.SGD","LU0053666078.USD","LU0820561818.USD","LU1720051108.HKD","LU2087621335.USD","BK4099","LU0823411888.USD","LU0345770993.USD","LU0943347566.SGD","IE00BSNM7G36.USD","LU1429558221.USD","LU2250418816.HKD","LU1435385759.SGD","IE00BK4W5L77.USD","BK4534","LU1861559042.SGD","LU1551013425.SGD","BK4511","BK4551","LU1861220033.SGD","BK4588","LU0345770308.USD","SG9999015952.SGD","LU0316494557.USD","LU1145028129.USD","LU1551013342.USD","TSLL","IE00BJLML261.HKD","IE00B1XK9C88.USD","LU0345769631.USD","TSLA","BK4581","LU1548497426.USD","LU0466842654.USD","LU0198837287.USD","LU0820562030.AUD","ABP"],"gpt_icon":0},{"id":"2503737872","title":"不满意马斯克薪酬方案,欧洲最大养老基金ABP清仓特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2503737872","media":"微博财经-财道工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503737872?lang=zh_cn&edition=full","pubTime":"2025-01-13 15:52","pubTimestamp":1736754720,"startTime":"0","endTime":"0","summary":"ABP发言人周日表示,马斯克的薪酬方案“有问题”。去年6月,ABP就曾投票反对马斯克薪酬方案,称其“有争议而且过高”。上个月,马斯克创纪录的特斯拉薪酬方案再次被特拉华州法官驳回。据悉,马斯克可以向特拉华州最高法院上诉该决定。不过,特斯拉的股价近期一路高歌。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"15049e06a9470364b90024adeef183b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-01-13/doc-ineevkuv2047912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1852331112.SGD","LU2360106780.USD","BK4548","BK4550","LU0964807845.USD","LU0097036916.USD","LU2756315664.SGD","LU0053666078.USD","BK4581","BK4585","IE00BSNM7G36.USD","LU0345770308.USD","BK4139","BK4598","ABP","IE00BK4W5L77.USD","LU1861559042.SGD","LU1914381329.SGD","BK4516","LU0820561909.HKD","LU2213496289.HKD","LU1548497426.USD","SG9999015952.SGD","BK4574","SG9999015978.USD","LU1429558221.USD","LU1720051017.SGD","LU1839511570.USD","BK4527","LU0348723411.USD","LU0198837287.USD","BK4511","LU0234570918.USD","TSLA","BK4592","IE00B1XK9C88.USD","IE00BWXC8680.SGD","LU1861220033.SGD","BK4588","BK4551","LU1145028129.USD","TSYW.SI","LU0820561818.USD","LU2087621335.USD","TSLL","LU0689472784.USD","LU0082616367.USD","LU0719512351.SGD","LU2357305700.SGD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.abpro.com","stockEarnings":[{"period":"1week","weight":-0.3172},{"period":"1month","weight":-0.676},{"period":"3month","weight":-0.7842},{"period":"6month","weight":-0.8409},{"period":"1year","weight":-0.9572},{"period":"ytd","weight":-0.6998}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":-0.0046},{"period":"3month","weight":0.0296},{"period":"6month","weight":0.0754},{"period":"1year","weight":0.1431},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Abpro Holdings, Inc.于2021年5月20日在特拉华州注册成立。该公司是一家生物技术公司,致力于开发下一代抗体疗法,旨在改善严重和危及生命的疾病患者的生活。Abpro专注于免疫肿瘤学和眼科的新型抗体构建。通过利用其专有的DiversImmune和MultiMabTM抗体发现和工程平台,Abpro正在独立或通过与全球制药和研究机构的合作开发下一代抗体管道。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.245192},{"month":2,"riseRate":0.25,"avgChangeRate":-0.176142},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.105402},{"month":4,"riseRate":0.5,"avgChangeRate":-0.105346},{"month":5,"riseRate":0.75,"avgChangeRate":-0.018772},{"month":6,"riseRate":0.5,"avgChangeRate":0.010148},{"month":7,"riseRate":0.75,"avgChangeRate":0.045161},{"month":8,"riseRate":0.5,"avgChangeRate":-0.012173},{"month":9,"riseRate":0.75,"avgChangeRate":-0.015241},{"month":10,"riseRate":0.75,"avgChangeRate":-0.040779},{"month":11,"riseRate":0.5,"avgChangeRate":-0.128557},{"month":12,"riseRate":0.25,"avgChangeRate":-0.177238}],"exchange":"NASDAQ","name":"ABPRO HLDGS INC","nameEN":"ABPRO HLDGS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ABPRO HLDGS INC(ABP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ABPRO HLDGS INC(ABP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ABPRO HLDGS INC,ABP,ABPRO HLDGS INC股票,ABPRO HLDGS INC股票老虎,ABPRO HLDGS INC股票老虎国际,ABPRO HLDGS INC行情,ABPRO HLDGS INC股票行情,ABPRO HLDGS INC股价,ABPRO HLDGS INC股市,ABPRO HLDGS INC股票价格,ABPRO HLDGS INC股票交易,ABPRO HLDGS INC股票购买,ABPRO HLDGS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ABPRO HLDGS INC(ABP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ABPRO HLDGS INC(ABP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}